Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Complement system WP2806,1.2430534972530543e-05,7.241071428571429,81.79046957498569,"['FCGR3A', 'CD93', 'PROS1', 'C5AR1', 'ITGAX', 'SPP1', 'F13A1', 'VSIG4', 'CD55', 'TLR2']",0.004027611830569745,0,0,10
2,Complement and Coagulation Cascades WP558,2.0549039951886454e-05,12.610864745011087,136.10523372453736,"['C1QB', 'C1QA', 'PROS1', 'C5AR1', 'PLAT', 'CD55', 'C1QC']",0.004027611830569745,0,0,7
3,Complement Activation WP545,8.747434617416008e-05,57.330396475770925,535.7046838507468,"['C1QB', 'C1QA', 'CD55', 'C1QC']",0.011429981233423583,0,0,4
4,"GPCRs, Class A Rhodopsin-like WP455",0.00018537124453768268,7.7545625106600715,66.63611896598456,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH2', 'GPR65']",0.0181663819646929,0,0,7
5,Oxidative Damage WP3941,0.0018133183553180822,5.746017699115044,36.27229274912989,"['C1QB', 'C1QA', 'C5AR1', 'CYCS', 'TNFRSF1B', 'C1QC']",0.13651966188337092,0,0,6
6,Nuclear Receptors Meta-Pathway WP2882,0.002089586661480167,2.470010590160778,15.241914185059732,"['STAT3', 'SLC6A1', 'SLC2A5', 'SLC5A3', 'SLC6A6', 'SCD', 'ENC1', 'PDE4B', 'BAX', 'FGF13', 'PLTP', 'CPEB4', 'PPARD', 'HSPA1A', 'FKBP5', 'FTL']",0.13651966188337092,0,0,16
7,Spinal Cord Injury WP2431,0.0026272505524486426,3.5056281225546257,20.829802165804903,"['C1QB', 'GJA1', 'ZFP36', 'GAP43', 'FCGR2A', 'TNFSF13', 'AIF1', 'TNFSF13B', 'RHOB']",0.13796991542315418,0,0,9
8,"GPCRs, Other WP117",0.002815712559656208,9.547723935389133,56.06938995458523,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADGRL2']",0.13796991542315418,0,0,4
9,PPAR signaling pathway WP3942,0.003800721490149648,4.786135693215339,26.671049207401346,"['FADS2', 'ACSL1', 'SCD', 'OLR1', 'PLTP', 'PPARD']",0.15447215084284957,0,0,6
10,Monoamine GPCRs WP58,0.0043139086599603225,inf,inf,"['CHRM3', 'HRH2']",0.15447215084284957,0,0,2
11,Endochondral Ossification with Skeletal Dysplasias WP4808,0.004728739311515804,4.533535165346996,24.272985406708973,"['HMGCS1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2']",0.15447215084284957,0,0,6
12,Endochondral Ossification WP474,0.004728739311515804,4.533535165346996,24.272985406708973,"['HMGCS1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2']",0.15447215084284957,0,0,6
13,NRF2 pathway WP2884,0.005328724728325491,3.3850980392156864,17.71978088053682,"['SLC6A6', 'FGF13', 'SLC2A5', 'SLC6A1', 'SLC5A3', 'FTL', 'PPARD', 'HSPA1A']",0.1606815456541225,0,0,8
14,Apoptosis Modulation and Signaling WP1772,0.007131446440754346,3.1960493827160494,15.79884298033033,"['CAPNS1', 'CASP4', 'CASP1', 'CYCS', 'BAX', 'TNFRSF1B', 'TNFRSF10D', 'HSPA1A']",0.19968050034112167,0,0,8
15,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.01232539561401935,8.575384615384616,37.69819223383521,"['CYSLTR1', 'LTC4S', 'PPARD']",0.30323242068209544,0,0,3
16,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.012376833497228385,28.539473684210527,125.3433369844553,"['STAT3', 'BAX']",0.30323242068209544,0,0,2
17,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.01407612017070667,3.442300884955752,14.675477103163423,"['RYR2', 'GJA1', 'CACNB4', 'CACNA2D3', 'CTNNA3', 'CACNA1C']",0.3245787709951185,0,0,6
18,Omega-9 FA synthesis WP4724,0.017597449947000472,7.145054945054945,28.866031100903044,"['FADS2', 'ACSL1', 'SCD']",0.38323335440134365,0,0,3
19,Acute viral myocarditis WP4298,0.020780060164716473,2.7903424488790343,10.809120865659578,"['STAT3', 'CASP1', 'CYCS', 'BAX', 'TLR5', 'AIF1', 'CD55']",0.4078929557401151,0,0,7
20,"GPCRs, Class B Secretin-like WP334",0.023679197849588447,14.267543859649123,53.40567584856015,"['ADGRE2', 'ADGRL2']",0.4078929557401151,0,0,2
21,Inflammatory Response Pathway WP453,0.023679197849588447,14.267543859649123,53.40567584856015,"['IL4R', 'TNFRSF1B']",0.4078929557401151,0,0,2
22,PTF1A related regulatory pathway WP4147,0.023679197849588447,14.267543859649123,53.40567584856015,"['NOTCH1', 'RBPJ']",0.4078929557401151,0,0,2
23,Iron metabolism in placenta WP2007,0.023932494852098588,6.123390894819466,22.85566750899512,"['STEAP3', 'TFRC', 'HAMP']",0.4078929557401151,0,0,3
24,Lung fibrosis WP3624,0.02698516545096281,4.086847073631215,14.763604240509126,"['CEBPB', 'SPP1', 'ATP11A', 'IGF1']",0.44075770236572587,0,0,4
25,Regulatory circuits of the STAT3 signaling pathway WP4538,0.028256158666779434,2.866371681415929,10.222753624174535,"['PTPRT', 'IFNAR2', 'IL10RB', 'STAT3', 'JAK3', 'CSF2RA']",0.4430565678951015,0,0,6
26,Genes controlling nephrogenesis WP4823,0.031333327948093355,5.357142857142857,18.552176556694384,"['ROBO2', 'CXCL12', 'NCK2']",0.4496889765414275,0,0,3
27,Toll-like Receptor Signaling Pathway WP75,0.031649994417011676,2.3434013605442177,8.09180545471372,"['IFNAR2', 'SPP1', 'LY96', 'MAP3K8', 'TLR5', 'IKBKE', 'MAP2K6', 'TLR2']",0.4496889765414275,0,0,8
28,Vitamin D Receptor Pathway WP2877,0.03588680327139612,2.4481639716618897,8.145985663173375,"['DUSP10', 'BCL6', 'SATB1', 'CREG2', 'SPP1', 'HIF1A', 'PPARD']",0.4496889765414275,0,0,7
29,HIF1A and PPARG regulation of glycolysis WP2456,0.03776198536117477,9.510233918128655,31.15982837153937,"['TPI1', 'HIF1A']",0.4496889765414275,0,0,2
30,NOTCH1 regulation of endothelial cell calcification WP3413,0.03776198536117477,9.510233918128655,31.15982837153937,"['NOTCH1', 'PLAT']",0.4496889765414275,0,0,2
31,TYROBP causal network in microglia WP3945,0.03959755714532466,2.3895048041389506,7.7156819821694365,"['IGSF6', 'DPYD', 'ITGAX', 'SPP1', 'TCIRG1', 'TNFRSF1B', 'C1QC']",0.4496889765414275,0,0,7
32,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.03978703617280534,4.761172161172161,15.351038624321722,"['STAT3', 'SPP1', 'IGF1']",0.4496889765414275,0,0,3
33,Monoamine Transport WP727,0.03978703617280534,4.761172161172161,15.351038624321722,"['SLC6A1', 'NECTIN2', 'STX1A']",0.4496889765414275,0,0,3
34,Statin inhibition of cholesterol production WP430,0.03978703617280534,4.761172161172161,15.351038624321722,"['LIPC', 'APOC1', 'PLTP']",0.4496889765414275,0,0,3
35,Synaptic Vesicle Pathway WP2267,0.04015080147691317,2.604585679806919,8.374036957676909,"['SNAP25', 'RAB3A', 'CACNA1A', 'SYN3', 'CPLX1', 'STX1A']",0.4496889765414275,0,0,6
36,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.04520799560725554,3.3640839595750194,10.416823118952419,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR2']",0.4910772379657555,0,0,4
37,Apoptosis WP254,0.04961000419471666,2.454993678887484,7.373727609864929,"['CASP4', 'CASP1', 'CYCS', 'BAX', 'IGF1', 'TNFRSF1B']",0.4910772379657555,0,0,6
38,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.05421231654705062,7.131578947368421,20.78746259674205,"['SPP1', 'ENPP1']",0.4910772379657555,0,0,2
39,Genes targeted by miRNAs in adipocytes WP1992,0.05421231654705062,7.131578947368421,20.78746259674205,"['GJA1', 'IGF1']",0.4910772379657555,0,0,2
40,Macrophage markers WP4146,0.05421231654705062,7.131578947368421,20.78746259674205,"['CD163', 'CD83']",0.4910772379657555,0,0,2
41,Pyrimidine metabolism and related diseases WP4225,0.05421231654705062,7.131578947368421,20.78746259674205,"['DPYD', 'TYMP']",0.4910772379657555,0,0,2
42,Transcriptional cascade regulating adipogenesis WP4211,0.05421231654705062,7.131578947368421,20.78746259674205,"['CEBPB', 'CEBPD']",0.4910772379657555,0,0,2
43,Adipogenesis WP236,0.056898364322670494,2.1803721199267327,6.250012010399478,"['CEBPB', 'CEBPD', 'SCD', 'STAT3', 'IGF1', 'HIF1A', 'PPARD']",0.4910772379657555,0,0,7
44,Allograft Rejection WP2328,0.06220344913777002,2.554399243140965,7.094447527603127,"['C1QB', 'C1QA', 'CXCL12', 'CD55', 'C1QC']",0.4910772379657555,0,0,5
45,"COVID-19, thrombosis and anticoagulation WP4927",0.0657476861870948,inf,inf,['F13A1'],0.4910772379657555,0,0,1
46,Gastric acid production WP2596,0.0657476861870948,inf,inf,['CCK'],0.4910772379657555,0,0,1
47,SCFA and skeletal muscle substrate metabolism WP4030,0.0657476861870948,inf,inf,['PPARD'],0.4910772379657555,0,0,1
48,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.0657476861870948,inf,inf,['HRH2'],0.4910772379657555,0,0,1
49,MECP2 and Associated Rett Syndrome WP3584,0.06616663857126819,2.260130414531905,6.137562447183499,"['RBFOX1', 'CEBPD', 'BCL6', 'YBX1', 'IGF1', 'FKBP5']",0.4910772379657555,0,0,6
50,Regulation of toll-like receptor signaling pathway WP1449,0.06882773433630555,1.8705335528226978,5.005825561434107,"['IFNAR2', 'SPP1', 'LY96', 'MAP3K8', 'SMAD6', 'TLR5', 'IKBKE', 'MAP2K6', 'TLR2']",0.4910772379657555,0,0,9
51,Notch Signaling Pathway Netpath WP61,0.0691727186930453,2.4659359062190758,6.586881570645781,"['NOTCH1', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.4910772379657555,0,0,5
52,Immune response to tuberculosis WP4197,0.07115591566668594,3.5692307692307694,9.433055091071747,"['IFNAR2', 'OAS1', 'PTPN2']",0.4910772379657555,0,0,3
53,7-oxo-C and 7beta-HC pathways WP5064,0.07265938725003525,5.704385964912281,14.956744186621371,"['DBP', 'ACOT7']",0.4910772379657555,0,0,2
54,Biomarkers for pyrimidine metabolism disorders WP4584,0.07265938725003525,5.704385964912281,14.956744186621371,"['DPYD', 'TYMP']",0.4910772379657555,0,0,2
55,Differentiation of white and brown adipocyte WP2895,0.07265938725003525,5.704385964912281,14.956744186621371,"['PLAC8', 'CEBPB']",0.4910772379657555,0,0,2
56,Dual hijack model of Vif in HIV infection WP3300,0.07265938725003525,5.704385964912281,14.956744186621371,"['ELOC', 'RUNX1']",0.4910772379657555,0,0,2
57,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.07265938725003525,5.704385964912281,14.956744186621371,"['IL10RB', 'STAT3']",0.4910772379657555,0,0,2
58,Nanomaterial induced apoptosis WP2507,0.07265938725003525,5.704385964912281,14.956744186621371,"['BAX', 'CYCS']",0.4910772379657555,0,0,2
59,Photodynamic therapy-induced unfolded protein response WP3613,0.08346698113430158,3.294167371090448,8.180419539158349,"['DNAJC3', 'XBP1', 'HSPA5']",0.5347960295567067,0,0,3
60,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.08558183428962604,2.093783725447874,5.147111335359302,"['HSPA5', 'TUBB3', 'PSMD5', 'CASP1', 'HSPA1B', 'HSPA1A']",0.5347960295567067,0,0,6
61,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.08749308920119424,2.5975170204245095,6.328059196576077,"['FADS2', 'HMGCS1', 'ACSL1', 'SCD']",0.5347960295567067,0,0,4
62,Exercise-induced Circadian Regulation WP410,0.09253625893778832,2.233719646799117,5.316598366638554,"['CEBPB', 'TUBB3', 'NR1D2', 'ERC2', 'ARNTL']",0.5347960295567067,0,0,5
63,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.09277073982106136,4.752923976608187,11.300666081601998,"['RYR2', 'CCK']",0.5347960295567067,0,0,2
64,Cori Cycle WP1946,0.09277073982106136,4.752923976608187,11.300666081601998,"['TPI1', 'PGAM1']",0.5347960295567067,0,0,2
65,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.09277073982106136,4.752923976608187,11.300666081601998,"['RAB27A', 'UNC13D']",0.5347960295567067,0,0,2
66,Fluoropyrimidine Activity WP1601,0.09277073982106136,4.752923976608187,11.300666081601998,"['DPYD', 'TYMP']",0.5347960295567067,0,0,2
67,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.09277073982106136,4.752923976608187,11.300666081601998,"['STAT3', 'JAK3']",0.5347960295567067,0,0,2
68,Omega-3/Omega-6 FA synthesis WP4723,0.09277073982106136,4.752923976608187,11.300666081601998,"['FADS2', 'ACSL1']",0.5347960295567067,0,0,2
69,Neovascularisation processes WP4331,0.0966156574731636,3.05839874411303,7.147522105508678,"['NOTCH1', 'CXCL12', 'HIF1A']",0.5488889526011613,0,0,3
70,Ferroptosis WP4313,0.1083153120911357,2.380323054331865,5.290764878514954,"['STEAP3', 'TFRC', 'ACSL1', 'FTL']",0.5892834956991507,0,0,4
71,3q29 copy number variation syndrome WP4906,0.11008576102854963,2.101675107128944,4.637336816068471,"['TFRC', 'DYNLT3', 'PXN', 'HIF1A', 'HAMP']",0.5892834956991507,0,0,5
72,Fatty acid beta-oxidation WP143,0.11054176525425259,2.8540659340659342,6.285685968626658,"['LIPC', 'TPI1', 'ACSL1']",0.5892834956991507,0,0,3
73,IL17 signaling pathway WP2112,0.11054176525425259,2.8540659340659342,6.285685968626658,"['CEBPB', 'CEBPD', 'STAT3']",0.5892834956991507,0,0,3
74,Oxysterols derived from cholesterol WP4545,0.11424884100289658,4.073308270676692,8.836538806481842,"['DBP', 'ACOT7']",0.5892834956991507,0,0,2
75,Peptide GPCRs WP24,0.11424884100289658,4.073308270676692,8.836538806481842,"['CX3CR1', 'C5AR1']",0.5892834956991507,0,0,2
76,Triacylglyceride synthesis WP325,0.11424884100289658,4.073308270676692,8.836538806481842,"['LIPC', 'PLPP3']",0.5892834956991507,0,0,2
77,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.11948575492891719,2.2847577092511013,4.8541005441802945,"['CEBPB', 'NOTCH1', 'CEBPD', 'SPP1']",0.5959617052451266,0,0,4
78,The influence of laminopathies on Wnt signaling WP4844,0.12518267075180076,2.675274725274725,5.559170697445451,"['CEBPB', 'CEBPD', 'SPP1']",0.5959617052451266,0,0,3
79,Blood Clotting Cascade WP272,0.12718154869536605,14.238512035010942,29.361800879716213,['PLAT'],0.5959617052451266,0,0,1
80,Dopaminergic Neurogenesis WP2855,0.12718154869536605,14.238512035010942,29.361800879716213,['STAT3'],0.5959617052451266,0,0,1
81,Gene regulatory network modelling somitogenesis  WP2854,0.12718154869536605,14.238512035010942,29.361800879716213,['NOTCH1'],0.5959617052451266,0,0,1
82,Hfe effect on hepcidin production WP3924,0.12718154869536605,14.238512035010942,29.361800879716213,['HAMP'],0.5959617052451266,0,0,1
83,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.12718154869536605,14.238512035010942,29.361800879716213,['NOTCH1'],0.5959617052451266,0,0,1
84,Microglia Pathogen Phagocytosis Pathway WP3937,0.13112968051857407,2.1965435445611656,4.462428713136959,"['C1QB', 'C1QA', 'FCER1G', 'C1QC']",0.5959617052451266,0,0,4
85,Apoptosis Modulation by HSP70 WP384,0.13682794253076888,3.56359649122807,7.0881040222078555,"['CYCS', 'HSPA1A']",0.5959617052451266,0,0,2
86,Canonical and non-canonical Notch signaling WP3845,0.13682794253076888,3.56359649122807,7.0881040222078555,"['NOTCH1', 'RBPJ']",0.5959617052451266,0,0,2
87,Cardiac Progenitor Differentiation WP2406,0.13682794253076888,3.56359649122807,7.0881040222078555,"['NOTCH1', 'IGF1']",0.5959617052451266,0,0,2
88,Development of ureteric collection system WP5053,0.13682794253076888,3.56359649122807,7.0881040222078555,"['ROBO2', 'GRIP1']",0.5959617052451266,0,0,2
89,Differentiation Pathway WP2848,0.13682794253076888,3.56359649122807,7.0881040222078555,"['NOTCH1', 'IGF1']",0.5959617052451266,0,0,2
90,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.13682794253076888,3.56359649122807,7.0881040222078555,"['HMGCS1', 'SCD']",0.5959617052451266,0,0,2
91,Oncostatin M Signaling Pathway WP2374,0.13916105168147053,1.9303740826919635,3.8069358439682266,"['CEBPB', 'PXN', 'STAT3', 'JAK3', 'HIF1A']",0.5985426888617885,0,0,5
92,Toll-like Receptor Signaling related to MyD88 WP3858,0.1404743045287871,2.5175177763413057,4.941209409420842,"['TLR5', 'IKBKE', 'TLR2']",0.5985426888617885,0,0,3
93,MAPK Signaling Pathway WP382,0.14603751006314383,1.4570190772972562,2.803147014504287,"['RPS6KA5', 'DUSP3', 'CACNB4', 'DUSP10', 'CACNA2D3', 'CACNA1A', 'MAP3K8', 'CACNA1C', 'FGF13', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.6155559563951869,0,0,12
94,Gastric Cancer Network 2 WP2363,0.16027120207423062,3.1671539961013644,5.798703883600755,"['PLAC8', 'RNF144B']",0.6518640323597372,0,0,2
95,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.16027120207423062,3.1671539961013644,5.798703883600755,"['IL4R', 'STAT3']",0.6518640323597372,0,0,2
96,Calcium Regulation in the Cardiac Cell WP536,0.16150683472477081,1.5671232876712329,2.857191428187276,"['RGS4', 'CHRM3', 'RYR2', 'GJA1', 'GNG3', 'CACNA1A', 'CACNA1C', 'YWHAG']",0.6518640323597372,0,0,8
97,Hematopoietic Stem Cell Differentiation WP2849,0.1727513717393665,2.2518218623481783,3.953978231978453,"['NOTCH1', 'PIM1', 'RUNX1']",0.6518640323597372,0,0,3
98,Non-small cell lung cancer WP4255,0.18247924939176677,1.740968071932375,2.961593542411346,"['STAT3', 'CYCS', 'BAX', 'E2F3', 'JAK3']",0.6518640323597372,0,0,5
99,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.18383790567798916,1.5627771618625277,2.646877018405335,"['RYR2', 'SNAP25', 'GJA1', 'CEBPB', 'YBX1', 'HIF1A', 'YWHAG']",0.6518640323597372,0,0,7
100,Fatty Acid Biosynthesis WP357,0.1843680442878341,2.85,4.818840643714128,"['ACSL1', 'SCD']",0.6518640323597372,0,0,2
101,Purinergic signaling WP4900,0.1843680442878341,2.85,4.818840643714128,"['P2RY12', 'P2RY13']",0.6518640323597372,0,0,2
102,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.1843680442878341,2.85,4.818840643714128,"['P4HA1', 'P3H2']",0.6518640323597372,0,0,2
103,EV release from cardiac cells and their functional effects WP3297,0.18458394793859906,7.1181619256017505,12.027208822146612,['CXCL12'],0.6518640323597372,0,0,1
104,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.18458394793859906,7.1181619256017505,12.027208822146612,['CEBPB'],0.6518640323597372,0,0,1
105,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.18458394793859906,7.1181619256017505,12.027208822146612,['FADS2'],0.6518640323597372,0,0,1
106,Liver X receptor pathway WP2874,0.18458394793859906,7.1181619256017505,12.027208822146612,['SCD'],0.6518640323597372,0,0,1
107,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.18458394793859906,7.1181619256017505,12.027208822146612,['HIF1A'],0.6518640323597372,0,0,1
108,Metabolism of alpha-linolenic acid WP4586,0.18458394793859906,7.1181619256017505,12.027208822146612,['FADS2'],0.6518640323597372,0,0,1
109,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.18458394793859906,7.1181619256017505,12.027208822146612,['HIF1A'],0.6518640323597372,0,0,1
110,Peroxiredoxin 2 induced ovarian failure WP4873,0.18458394793859906,7.1181619256017505,12.027208822146612,['BAX'],0.6518640323597372,0,0,1
111,Sulfation Biotransformation Reaction WP692,0.18458394793859906,7.1181619256017505,12.027208822146612,['SULT4A1'],0.6518640323597372,0,0,1
112,Neural Crest Differentiation WP2064,0.18960864116151155,2.138901098901099,3.5565500197495354,"['NOTCH1', 'RBPJ', 'RHOB']",0.6636302440652904,0,0,3
113,IL-4 signaling pathway WP395,0.1954837119608326,1.840841267585619,3.004765103518273,"['CEBPB', 'IL4R', 'STAT3', 'JAK3']",0.6781381866251892,0,0,4
114,Disruption of postsynaptic signaling by CNV WP4875,0.20686143673689172,2.036734693877551,3.20929527633889,"['RYR2', 'YWHAG', 'STX1A']",0.6866308997036024,0,0,3
115,IL-9 signaling pathway WP22,0.20893174254848115,2.590510366826156,4.056085573654738,"['STAT3', 'JAK3']",0.6866308997036024,0,0,2
116,SARS coronavirus and innate immunity WP4912,0.20893174254848115,2.590510366826156,4.056085573654738,"['IFNAR2', 'IKBKE']",0.6866308997036024,0,0,2
117,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.20893174254848115,2.590510366826156,4.056085573654738,"['TLR5', 'TLR2']",0.6866308997036024,0,0,2
118,Transcription factor regulation in adipogenesis WP3599,0.20893174254848115,2.590510366826156,4.056085573654738,"['CEBPB', 'CEBPD']",0.6866308997036024,0,0,2
119,7q11.23 copy number variation syndrome WP4932,0.21036661297415848,1.557441673370877,2.4279012667754767,"['GRIP1', 'SNAP25', 'VPS9D1', 'ATP5MC3', 'STX1A', 'ATP5MC1']",0.6866308997036024,0,0,6
120,Glycolysis and Gluconeogenesis WP534,0.22444906803337392,1.943856143856144,2.9043280334832247,"['TPI1', 'PGAM1', 'SLC2A5']",0.6866308997036024,0,0,3
121,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.2271208010600809,1.3326128995563644,1.975296440010183,"['IFNAR2', 'GNG10', 'GNG3', 'IL4R', 'SPP1', 'ITGAX', 'IGF1', 'FGF13', 'HIF1A', 'JAK3', 'CREB5']",0.6866308997036024,0,0,11
122,TNF-alpha signaling pathway WP231,0.23190604103561774,1.5023288309268747,2.1955378843716438,"['BAX', 'MAP3K8', 'PYGL', 'KSR2', 'TNFRSF1B', 'MAP2K6']",0.6866308997036024,0,0,6
123,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.23379720418438543,2.374269005847953,3.4505279672252183,"['FCGR2A', 'IKBKE']",0.6866308997036024,0,0,2
124,White fat cell differentiation WP4149,0.23379720418438543,2.374269005847953,3.4505279672252183,"['CEBPB', 'CEBPD']",0.6866308997036024,0,0,2
125,PI3K-Akt signaling pathway WP4172,0.2346158953067445,1.3212076777019532,1.9154942768514183,"['IFNAR2', 'GNG10', 'GNG3', 'IL4R', 'SPP1', 'IGF1', 'FGF13', 'PIK3AP1', 'JAK3', 'TLR2', 'CREB5']",0.6866308997036024,0,0,11
126,Caloric restriction and aging WP4191,0.23821888357063756,4.74471188913202,6.806599267554353,['IGF1'],0.6866308997036024,0,0,1
127,Cysteine and methionine catabolism WP4504,0.23821888357063756,4.74471188913202,6.806599267554353,['SQOR'],0.6866308997036024,0,0,1
128,Farnesoid X receptor pathway WP2879,0.23821888357063756,4.74471188913202,6.806599267554353,['FKBP5'],0.6866308997036024,0,0,1
129,Glutathione metabolism WP100,0.23821888357063756,4.74471188913202,6.806599267554353,['IDH1'],0.6866308997036024,0,0,1
130,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.23821888357063756,4.74471188913202,6.806599267554353,['LIPC'],0.6866308997036024,0,0,1
131,Metastatic brain tumor WP2249,0.23821888357063756,4.74471188913202,6.806599267554353,['E2F3'],0.6866308997036024,0,0,1
132,Mevalonate pathway WP3963,0.23821888357063756,4.74471188913202,6.806599267554353,['HMGCS1'],0.6866308997036024,0,0,1
133,Role of Osx and miRNAs in tooth development WP3971,0.23821888357063756,4.74471188913202,6.806599267554353,['NOTCH1'],0.6866308997036024,0,0,1
134,Serotonin Transporter Activity WP1455,0.23821888357063756,4.74471188913202,6.806599267554353,['STX1A'],0.6866308997036024,0,0,1
135,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.23821888357063756,4.74471188913202,6.806599267554353,['STAT3'],0.6866308997036024,0,0,1
136,Thiamine metabolic pathways WP4297,0.23821888357063756,4.74471188913202,6.806599267554353,['SLC25A19'],0.6866308997036024,0,0,1
137,Amyotrophic lateral sclerosis (ALS) WP2447,0.24231289273446166,1.859053989488772,2.6352563295937643,"['CASP1', 'BAX', 'MAP2K6']",0.693333240524883,0,0,3
138,Hepatitis B infection WP4666,0.25718113582614244,1.3595767195767197,1.8462706977350263,"['STAT3', 'CYCS', 'BAX', 'IKBKE', 'JAK3', 'MAP2K6', 'CREB5', 'TLR2']",0.7239394391578631,0,0,8
139,Nuclear receptors WP170,0.25881894292623464,2.1912955465587043,2.9618131822163805,"['NR1D2', 'PPARD']",0.7239394391578631,0,0,2
140,Overview of interferons-mediated signaling pathway WP4558,0.25881894292623464,2.1912955465587043,2.9618131822163805,"['IFNAR2', 'IL10RB']",0.7239394391578631,0,0,2
141,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2603965839828028,1.7813186813186814,2.39685243797327,"['IFNAR2', 'OAS1', 'IKBKE']",0.7239394391578631,0,0,3
142,Bladder cancer WP2828,0.28386922331963305,2.0344611528822054,2.5618781745508774,"['RPS6KA5', 'TYMP']",0.7525797252206228,0,0,2
143,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.28386922331963305,2.0344611528822054,2.5618781745508774,"['PTPN1', 'CEBPB']",0.7525797252206228,0,0,2
144,Unfolded protein response WP4925,0.28386922331963305,2.0344611528822054,2.5618781745508774,"['XBP1', 'HSPA5']",0.7525797252206228,0,0,2
145,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.2883331139559851,3.5579868708971554,4.424850599266107,['CASP1'],0.7525797252206228,0,0,1
146,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.2883331139559851,3.5579868708971554,4.424850599266107,['NOTCH1'],0.7525797252206228,0,0,1
147,Cell Differentiation - Index WP2029,0.2883331139559851,3.5579868708971554,4.424850599266107,['STAT3'],0.7525797252206228,0,0,1
148,GDNF/RET signaling axis WP4830,0.2883331139559851,3.5579868708971554,4.424850599266107,['ROBO2'],0.7525797252206228,0,0,1
149,Hedgehog Signaling Pathway Netpath WP47,0.2883331139559851,3.5579868708971554,4.424850599266107,['ARNTL'],0.7525797252206228,0,0,1
150,Nanomaterial-induced inflammasome activation WP3890,0.2883331139559851,3.5579868708971554,4.424850599266107,['CASP1'],0.7525797252206228,0,0,1
151,Glucocorticoid Receptor Pathway WP2880,0.2970110174958344,1.6437869822485207,1.9955344572739948,"['ENC1', 'PDE4B', 'CPEB4']",0.7525797252206228,0,0,3
152,Signaling of Hepatocyte Growth Factor Receptor WP313,0.2970110174958344,1.6437869822485207,1.9955344572739948,"['PXN', 'STAT3', 'DOCK1']",0.7525797252206228,0,0,3
153,Interferon type I signaling pathways WP585,0.2973540550708002,1.5001159285879897,1.8193882202064136,"['IFNAR2', 'RPS6KA5', 'STAT3', 'MAP2K6']",0.7525797252206228,0,0,4
154,Pathogenic Escherichia coli infection WP2272,0.2973540550708002,1.5001159285879897,1.8193882202064136,"['TUBB3', 'NCK2', 'LY96', 'TLR5']",0.7525797252206228,0,0,4
155,Integrin-mediated Cell Adhesion WP185,0.30677311772860316,1.3974375622213566,1.651277672246776,"['CAPNS1', 'PXN', 'ITGAX', 'DOCK1', 'MAP2K6']",0.7525797252206228,0,0,5
156,Myometrial relaxation and contraction pathways WP289,0.31435137931507995,1.2963112275750857,1.5001482299296176,"['RGS4', 'RYR2', 'GJA1', 'GNG3', 'PDE4D', 'PDE4B', 'YWHAG']",0.7525797252206228,0,0,7
157,Regulation of Actin Cytoskeleton WP51,0.31435137931507995,1.2963112275750857,1.5001482299296176,"['CHRM3', 'PXN', 'IQGAP1', 'PFN1', 'SSH2', 'FGF13', 'DOCK1']",0.7525797252206228,0,0,7
158,TGF-beta Receptor Signaling WP560,0.3154422752017314,1.5826617826617826,1.8260428415814547,"['STAT3', 'SPP1', 'SMAD6']",0.7525797252206228,0,0,3
159,IL-7 signaling pathway WP205,0.33362318558585574,1.7796052631578947,1.9535494157170865,"['STAT3', 'JAK3']",0.7525797252206228,0,0,2
160,p53 transcriptional gene network WP4963,0.33389460208311267,1.5259026687598116,1.6738082594586126,"['NOTCH1', 'BAX', 'TNFRSF10D']",0.7525797252206228,0,0,3
161,15q13.3 copy number variation syndrome WP4942,0.3351572709228602,2.8459518599562363,3.1110676207424155,['OTUD7A'],0.7525797252206228,0,0,1
162,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.3351572709228602,2.8459518599562363,3.1110676207424155,['TLR2'],0.7525797252206228,0,0,1
163,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.3351572709228602,2.8459518599562363,3.1110676207424155,['SMAD6'],0.7525797252206228,0,0,1
164,Cytokines and Inflammatory Response WP530,0.3351572709228602,2.8459518599562363,3.1110676207424155,['IL15'],0.7525797252206228,0,0,1
165,Fatty acid transporters WP5061,0.3351572709228602,2.8459518599562363,3.1110676207424155,['ACSL1'],0.7525797252206228,0,0,1
166,FOXP3 in COVID-19 WP5063,0.3351572709228602,2.8459518599562363,3.1110676207424155,['STAT3'],0.7525797252206228,0,0,1
167,Glial Cell Differentiation WP2276,0.3351572709228602,2.8459518599562363,3.1110676207424155,['GAP43'],0.7525797252206228,0,0,1
168,LDLRAD4 and what we know about it WP4904,0.3351572709228602,2.8459518599562363,3.1110676207424155,['PMEPA1'],0.7525797252206228,0,0,1
169,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.3351572709228602,2.8459518599562363,3.1110676207424155,['HMGCS1'],0.7525797252206228,0,0,1
170,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.3351572709228602,2.8459518599562363,3.1110676207424155,['PPARD'],0.7525797252206228,0,0,1
171,Osteoclast Signaling WP12,0.3351572709228602,2.8459518599562363,3.1110676207424155,['SPP1'],0.7525797252206228,0,0,1
172,Platelet-mediated interactions with vascular and circulating cells WP4462,0.3351572709228602,2.8459518599562363,3.1110676207424155,['TLR2'],0.7525797252206228,0,0,1
173,Selective expression of chemokine receptors during T-cell polarization WP4494,0.3351572709228602,2.8459518599562363,3.1110676207424155,['IL4R'],0.7525797252206228,0,0,1
174,Urea cycle and metabolism of amino groups WP497,0.3351572709228602,2.8459518599562363,3.1110676207424155,['OAT'],0.7525797252206228,0,0,1
175,Chemokine signaling pathway WP3929,0.3359730916163494,1.263100283476943,1.3776940546792171,"['CX3CR1', 'GNG10', 'GNG3', 'CXCL12', 'PXN', 'STAT3', 'JAK3']",0.7525797252206228,0,0,7
176,ESC Pluripotency Pathways WP3931,0.3430162028911847,1.3897066723971205,1.4869550019502857,"['STAT3', 'SMAD6', 'FGF13', 'MAP2K6']",0.763990633712184,0,0,4
177,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3581455946384857,1.6746646026831786,1.7195718833643743,"['RAB3A', 'LITAF']",0.7799615172127021,0,0,2
178,Nanoparticle triggered autophagic cell death WP2509,0.3581455946384857,1.6746646026831786,1.7195718833643743,"['VMP1', 'ATG14']",0.7799615172127021,0,0,2
179,Notch Signaling WP268,0.3581455946384857,1.6746646026831786,1.7195718833643743,"['NOTCH1', 'RBPJ']",0.7799615172127021,0,0,2
180,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3581455946384857,1.6746646026831786,1.7195718833643743,"['BAX', 'HIF1A']",0.7799615172127021,0,0,2
181,Pyrimidine metabolism WP4022,0.37069482204338705,1.4237362637362638,1.4128818934768081,"['DPYD', 'ENPP1', 'TYMP']",0.7900612170153589,0,0,3
182,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.37069482204338705,1.4237362637362638,1.4128818934768081,"['STAT3', 'SPP1', 'SMAD6']",0.7900612170153589,0,0,3
183,Cell Differentiation - Index expanded WP2023,0.37890691020124356,2.37126185266229,2.3012259784055797,['STAT3'],0.7900612170153589,0,0,1
184,Development and heterogeneity of the ILC family WP3893,0.37890691020124356,2.37126185266229,2.3012259784055797,['IL15'],0.7900612170153589,0,0,1
185,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.37890691020124356,2.37126185266229,2.3012259784055797,['STAT3'],0.7900612170153589,0,0,1
186,Estrogen Receptor Pathway WP2881,0.37890691020124356,2.37126185266229,2.3012259784055797,['STAT3'],0.7900612170153589,0,0,1
187,Nanoparticle triggered regulated necrosis WP2513,0.37890691020124356,2.37126185266229,2.3012259784055797,['FTL'],0.7900612170153589,0,0,1
188,Type III interferon signaling WP2113,0.37890691020124356,2.37126185266229,2.3012259784055797,['IL10RB'],0.7900612170153589,0,0,1
189,Parkinson's disease pathway WP2371,0.38233128781420905,1.581384015594542,1.5204498114232239,"['PINK1', 'CYCS']",0.792983411762804,0,0,2
190,Melatonin metabolism and effects WP3298,0.4061185714167032,1.4979224376731302,1.349793058864905,"['PER3', 'ARNTL']",0.8007178028157685,0,0,2
191,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4071050371536586,1.3343406593406593,1.1991506682041595,"['PXN', 'STAT3', 'BAX']",0.8007178028157685,0,0,3
192,BMP Signaling Pathway in Eyelid Development WP3927,0.41978349413539684,2.0321975617380432,1.7639803864304495,['NOTCH1'],0.8007178028157685,0,0,1
193,Cytosine methylation WP3585,0.41978349413539684,2.0321975617380432,1.7639803864304495,['IDH1'],0.8007178028157685,0,0,1
194,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.41978349413539684,2.0321975617380432,1.7639803864304495,['PPARD'],0.8007178028157685,0,0,1
195,ERK Pathway in Huntington's Disease WP3853,0.41978349413539684,2.0321975617380432,1.7639803864304495,['RPS6KA5'],0.8007178028157685,0,0,1
196,Globo Sphingolipid Metabolism WP1424,0.41978349413539684,2.0321975617380432,1.7639803864304495,['ST6GALNAC5'],0.8007178028157685,0,0,1
197,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.41978349413539684,2.0321975617380432,1.7639803864304495,['ELOC'],0.8007178028157685,0,0,1
198,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.41978349413539684,2.0321975617380432,1.7639803864304495,['ACSL1'],0.8007178028157685,0,0,1
199,"NAD metabolism, sirtuins and aging WP3630",0.41978349413539684,2.0321975617380432,1.7639803864304495,['HIF1A'],0.8007178028157685,0,0,1
200,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.41978349413539684,2.0321975617380432,1.7639803864304495,['IGF1'],0.8007178028157685,0,0,1
201,Ovarian infertility WP34,0.41978349413539684,2.0321975617380432,1.7639803864304495,['CEBPB'],0.8007178028157685,0,0,1
202,Overview of nanoparticle effects WP3287,0.41978349413539684,2.0321975617380432,1.7639803864304495,['BAX'],0.8007178028157685,0,0,1
203,Proteoglycan biosynthesis WP4784,0.41978349413539684,2.0321975617380432,1.7639803864304495,['CHSY1'],0.8007178028157685,0,0,1
204,RalA downstream regulated genes WP2290,0.41978349413539684,2.0321975617380432,1.7639803864304495,['YBX3'],0.8007178028157685,0,0,1
205,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.41978349413539684,2.0321975617380432,1.7639803864304495,['STAT3'],0.8007178028157685,0,0,1
206,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.4294552835207232,1.4228070175438596,1.2026100682381222,"['LY96', 'PLAT']",0.8007178028157685,0,0,2
207,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4294552835207232,1.4228070175438596,1.2026100682381222,"['CASP1', 'NLRP1']",0.8007178028157685,0,0,2
208,Prion disease pathway WP3995,0.4294552835207232,1.4228070175438596,1.2026100682381222,"['HSPA5', 'STAT3']",0.8007178028157685,0,0,2
209,Type 2 papillary renal cell carcinoma WP4241,0.4294552835207232,1.4228070175438596,1.2026100682381222,"['ELOC', 'HIF1A']",0.8007178028157685,0,0,2
210,22q11.2 copy number variation syndrome WP4657,0.4428635047906841,1.2554621848739496,1.0225660050289542,"['OAT', 'EMC10', 'ARNTL']",0.8007178028157685,0,0,3
211,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.4428635047906841,1.2554621848739496,1.0225660050289542,"['RPS6KA5', 'MAP3K8', 'MAP2K6']",0.8007178028157685,0,0,3
212,Prolactin Signaling Pathway WP2037,0.4491481266901477,1.1857562408223201,0.9490823094705306,"['PTPN1', 'PXN', 'STAT3', 'YWHAG']",0.8007178028157685,0,0,4
213,Integrated Cancer Pathway WP1971,0.45229781211842657,1.35484544695071,1.0749539412340625,"['BAX', 'BACH1']",0.8007178028157685,0,0,2
214,1q21.1 copy number variation syndrome WP4905,0.45797531116776263,1.7778993435448578,1.3884327170249056,['GJA1'],0.8007178028157685,0,0,1
215,Cholesterol Biosynthesis Pathway WP197,0.45797531116776263,1.7778993435448578,1.3884327170249056,['HMGCS1'],0.8007178028157685,0,0,1
216,Computational Model of Aerobic Glycolysis WP4629,0.45797531116776263,1.7778993435448578,1.3884327170249056,['TPI1'],0.8007178028157685,0,0,1
217,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.45797531116776263,1.7778993435448578,1.3884327170249056,['BAX'],0.8007178028157685,0,0,1
218,Leptin Insulin Overlap WP3935,0.45797531116776263,1.7778993435448578,1.3884327170249056,['STAT3'],0.8007178028157685,0,0,1
219,LTF danger signal response pathway WP4478,0.45797531116776263,1.7778993435448578,1.3884327170249056,['TLR2'],0.8007178028157685,0,0,1
220,Osteopontin Signaling WP1434,0.45797531116776263,1.7778993435448578,1.3884327170249056,['SPP1'],0.8007178028157685,0,0,1
221,Phytochemical activity on NRF2 transcriptional activation WP3,0.45797531116776263,1.7778993435448578,1.3884327170249056,['CEBPB'],0.8007178028157685,0,0,1
222,PPAR-alpha pathway WP2878,0.45797531116776263,1.7778993435448578,1.3884327170249056,['PLTP'],0.8007178028157685,0,0,1
223,TP53 network WP1742,0.45797531116776263,1.7778993435448578,1.3884327170249056,['BAX'],0.8007178028157685,0,0,1
224,Urea cycle and associated pathways WP4595,0.45797531116776263,1.7778993435448578,1.3884327170249056,['OAT'],0.8007178028157685,0,0,1
225,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.46395318598633684,1.1613773262609008,0.8919048314608656,"['STAT3', 'IGF1', 'IKBKE', 'MAP2K6']",0.8007178028157685,0,0,4
226,Ectoderm Differentiation WP2858,0.4657780104874638,1.1291565927327516,0.8627277256344992,"['PLCXD3', 'PIM1', 'SORCS1', 'ASTN1', 'PPARD']",0.8007178028157685,0,0,5
227,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4746102002828615,1.2930622009569377,0.9636694015578245,"['STAT3', 'HIF1A']",0.8007178028157685,0,0,2
228,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.4746102002828615,1.2930622009569377,0.9636694015578245,"['BAX', 'MAP2K6']",0.8007178028157685,0,0,2
229,Small cell lung cancer WP4658,0.4777512847597247,1.1853479853479854,0.875575077511686,"['CYCS', 'BAX', 'E2F3']",0.8007178028157685,0,0,3
230,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.4777512847597247,1.1853479853479854,0.875575077511686,"['RPS6KA5', 'PIM1', 'MAP2K6']",0.8007178028157685,0,0,3
231,Autosomal recessive Osteopetrosis pathways WP4788,0.4936583355436001,1.5801118405057135,1.11541932417698,['TCIRG1'],0.8007178028157685,0,0,1
232,Cancer immunotherapy by PD-1 blockade WP4585,0.4936583355436001,1.5801118405057135,1.11541932417698,['STAT3'],0.8007178028157685,0,0,1
233,Eicosanoid Synthesis WP167,0.4936583355436001,1.5801118405057135,1.11541932417698,['LTC4S'],0.8007178028157685,0,0,1
234,Gastric Cancer Network 1 WP2361,0.4936583355436001,1.5801118405057135,1.11541932417698,['NOTCH1'],0.8007178028157685,0,0,1
235,IL1 and megakaryocytes in obesity WP2865,0.4936583355436001,1.5801118405057135,1.11541932417698,['TLR2'],0.8007178028157685,0,0,1
236,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.4936583355436001,1.5801118405057135,1.11541932417698,['MAP2K6'],0.8007178028157685,0,0,1
237,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4936583355436001,1.5801118405057135,1.11541932417698,['OAS1'],0.8007178028157685,0,0,1
238,Sleep regulation WP3591,0.4936583355436001,1.5801118405057135,1.11541932417698,['PER3'],0.8007178028157685,0,0,1
239,Vitamin B12 metabolism WP1533,0.4936583355436001,1.5801118405057135,1.11541932417698,['PLAT'],0.8007178028157685,0,0,1
240,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.4936583355436001,1.5801118405057135,1.11541932417698,['PPARD'],0.8007178028157685,0,0,1
241,Metabolic reprogramming in colon cancer WP4290,0.49636333184753,1.236651411136537,0.8662088903574034,"['PGAM1', 'SLC16A3']",0.8007178028157685,0,0,2
242,NO/cGMP/PKG mediated Neuroprotection WP4008,0.49636333184753,1.236651411136537,0.8662088903574034,"['TSPO', 'CYCS']",0.8007178028157685,0,0,2
243,p38 MAPK Signaling Pathway WP400,0.49636333184753,1.236651411136537,0.8662088903574034,"['RPS6KA5', 'MAP2K6']",0.8007178028157685,0,0,2
244,Senescence and Autophagy in Cancer WP615,0.5074558874959649,1.0938664859369704,0.7420194007165865,"['CEBPB', 'PLAT', 'IGF1', 'ATG14']",0.8117767167673023,0,0,4
245,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5101451233097242,1.0477535301668806,0.7052010310726118,"['GRIP1', 'RAB3A', 'RPS6KA5', 'STAT3', 'NCK2', 'SPP1', 'YBX1']",0.8117767167673023,0,0,7
246,Cardiac Hypertrophic Response WP2795,0.511589404145812,1.1226142278773859,0.752413012769941,"['IGF1', 'IKBKE', 'MAP2K6']",0.8117767167673023,0,0,3
247,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.517534190744804,1.1849415204678362,0.7804969097593578,"['BST2', 'MAP2K6']",0.8117767167673023,0,0,2
248,Phosphodiesterases in neuronal function WP4222,0.517534190744804,1.1849415204678362,0.7804969097593578,"['PDE4D', 'PDE4B']",0.8117767167673023,0,0,2
249,Breast cancer pathway WP4262,0.5216066383604332,1.0730612584157593,0.6983928435863016,"['NOTCH1', 'BAX', 'E2F3', 'IGF1']",0.8117767167673023,0,0,4
250,Angiogenesis WP1539,0.5269970307670715,1.4218818380743983,0.9108011487213086,['HIF1A'],0.8117767167673023,0,0,1
251,Imatinib and Chronic Myeloid Leukemia WP3640,0.5269970307670715,1.4218818380743983,0.9108011487213086,['PIM1'],0.8117767167673023,0,0,1
252,Pre-implantation embryo WP3527,0.5269970307670715,1.4218818380743983,0.9108011487213086,['ZFP36'],0.8117767167673023,0,0,1
253,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.5269970307670715,1.4218818380743983,0.9108011487213086,['IDH1'],0.8117767167673023,0,0,1
254,Type II diabetes mellitus WP1584,0.5269970307670715,1.4218818380743983,0.9108011487213086,['CACNA1A'],0.8117767167673023,0,0,1
255,AGE/RAGE pathway WP2324,0.5280690376930155,1.0936601859678783,0.6983329253153816,"['STAT3', 'CYCS', 'HIF1A']",0.8117767167673023,0,0,3
256,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5355620170342326,1.0530265948768152,0.6575504361823172,"['NOTCH1', 'RBPJ', 'HIF1A', 'MAP2K6']",0.8200793385836687,0,0,4
257,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.53810518762634,1.1373684210526316,0.7048286002734142,"['XBP1', 'HSPA5']",0.8207674457179971,0,0,2
258,G Protein Signaling Pathways WP35,0.5493114108522038,1.033720464557469,0.6192913506075217,"['GNG10', 'GNG3', 'PDE4D', 'PDE4B']",0.8319120898366832,0,0,4
259,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.5581451010894073,1.292420926994231,0.7536575737076163,['MAP2K6'],0.8319120898366832,0,0,1
260,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5581451010894073,1.292420926994231,0.7536575737076163,['HIF1A'],0.8319120898366832,0,0,1
261,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.5581451010894073,1.292420926994231,0.7536575737076163,['PXN'],0.8319120898366832,0,0,1
262,PKC-gamma calcium signaling pathway in ataxia WP4760,0.5581451010894073,1.292420926994231,0.7536575737076163,['CACNA1A'],0.8319120898366832,0,0,1
263,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5581451010894073,1.292420926994231,0.7536575737076163,['BAX'],0.8319120898366832,0,0,1
264,Insulin Signaling WP481,0.5618854086702615,0.994589800443459,0.5733385997477908,"['SNAP25', 'PTPN1', 'XBP1', 'RPS6KA5', 'ENPP1', 'MAP3K8', 'MAP2K6']",0.8343146977225094,0,0,7
265,IL-18 signaling pathway WP4754,0.565539802648972,0.9882898550724638,0.5633001158410365,"['CEBPB', 'NRN1', 'CD83', 'NFKBIZ', 'SPP1', 'TNFAIP2', 'CYCS', 'BAX']",0.8365720854279132,0,0,8
266,Androgen receptor signaling pathway WP138,0.5761547764602931,0.9971404281629183,0.5498022375462297,"['LIMK2', 'STAT3', 'DSTN', 'RHOB']",0.849070196888853,0,0,4
267,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5872461941118606,1.1845368344274252,0.6305421483580955,['BCL6'],0.8494483693426176,0,0,1
268,Folate Metabolism WP176,0.5872461941118606,1.1845368344274252,0.6305421483580955,['PLAT'],0.8494483693426176,0,0,1
269,Heart Development WP1591,0.5872461941118606,1.1845368344274252,0.6305421483580955,['NOTCH1'],0.8494483693426176,0,0,1
270,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5872461941118606,1.1845368344274252,0.6305421483580955,['RPS6KA5'],0.8494483693426176,0,0,1
271,Sphingolipid Metabolism (general overview) WP4725,0.5872461941118606,1.1845368344274252,0.6305421483580955,['PLPP3'],0.8494483693426176,0,0,1
272,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5961120673976069,1.0150375939849625,0.5251059443703762,"['IFNAR2', 'CXCL12']",0.8541076110211919,0,0,2
273,Alzheimer's disease WP2059,0.6055451363050892,0.9686313686313687,0.485890848345148,"['VMP1', 'CYCS', 'CACNA1C']",0.8541076110211919,0,0,3
274,Cytosolic DNA-sensing pathway WP4655,0.6141960168303728,0.9798850574712644,0.4776363052892568,"['CASP1', 'IKBKE']",0.8541076110211919,0,0,2
275,IL-2 signaling pathway WP49,0.6141960168303728,0.9798850574712644,0.4776363052892568,"['STAT3', 'JAK3']",0.8541076110211919,0,0,2
276,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6141960168303728,0.9798850574712644,0.4776363052892568,"['ATG14', 'FTL']",0.8541076110211919,0,0,2
277,Selenium Micronutrient Network WP15,0.6141960168303728,0.9798850574712644,0.4776363052892568,"['PRDX5', 'PLAT']",0.8541076110211919,0,0,2
278,Cell migration and invasion through p75NTR WP4561,0.6144345569081023,1.0932502945632048,0.5324706758439749,['STAT3'],0.8541076110211919,0,0,1
279,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6144345569081023,1.0932502945632048,0.5324706758439749,['RAB27A'],0.8541076110211919,0,0,1
280,MTHFR deficiency WP4288,0.6144345569081023,1.0932502945632048,0.5324706758439749,['CYCS'],0.8541076110211919,0,0,1
281,NRF2-ARE regulation WP4357,0.6144345569081023,1.0932502945632048,0.5324706758439749,['CEBPB'],0.8541076110211919,0,0,1
282,Sphingolipid Metabolism (integrated pathway) WP4726,0.6144345569081023,1.0932502945632048,0.5324706758439749,['PLPP3'],0.8541076110211919,0,0,1
283,16p11.2 proximal deletion syndrome WP4949,0.6199920022638761,0.946959706959707,0.4526928574332067,"['ASPHD1', 'MVP', 'MAP2K6']",0.8557636087585895,0,0,3
284,Pathways in clear cell renal cell carcinoma WP4018,0.6199920022638761,0.946959706959707,0.4526928574332067,"['TPI1', 'STAT3', 'HIF1A']",0.8557636087585895,0,0,3
285,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6398356505895594,1.0150046889653017,0.4532441843623599,['BAX'],0.870575764699845,0,0,1
286,SARS-CoV-2 mitochondrial interactions WP5038,0.6398356505895594,1.0150046889653017,0.4532441843623599,['IKBKE'],0.870575764699845,0,0,1
287,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6477924675229549,0.9063829787234042,0.39353780306419855,"['STAT3', 'BAX', 'IGF1']",0.870575764699845,0,0,3
288,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6477924675229549,0.9063829787234042,0.39353780306419855,"['PDE4D', 'STAT3', 'MAP2K6']",0.870575764699845,0,0,3
289,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6484901104396804,0.916383701188455,0.39689359337770314,"['HSPA5', 'YBX3']",0.870575764699845,0,0,2
290,DNA damage response WP707,0.6484901104396804,0.916383701188455,0.39689359337770314,"['CYCS', 'BAX']",0.870575764699845,0,0,2
291,G13 Signaling Pathway WP524,0.6484901104396804,0.916383701188455,0.39689359337770314,"['IQGAP1', 'PFN1']",0.870575764699845,0,0,2
292,miRNA regulation of DNA damage response WP1530,0.6484901104396804,0.916383701188455,0.39689359337770314,"['CYCS', 'BAX']",0.870575764699845,0,0,2
293,Hippo-Merlin Signaling Dysregulation WP4541,0.661140938121607,0.8873626373626373,0.36718022600579364,"['ITGAX', 'CDH12', 'CDH18']",0.8787788445662238,0,0,3
294,Proximal tubule transport WP4917,0.6635667235774512,0.9471918307804522,0.38846787102762714,['ATP6V1F'],0.8787788445662238,0,0,1
295,Vitamin D in inflammatory diseases WP4482,0.6635667235774512,0.9471918307804522,0.38846787102762714,['MAP2K6'],0.8787788445662238,0,0,1
296,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6647103480679037,0.887609649122807,0.3625032424044561,"['CXCL12', 'IKBKE']",0.8787788445662238,0,0,2
297,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6658094817249196,0.8868653421633554,0.36073399698497877,"['PTPN1', 'RPS6KA5', 'SCD', 'MAP3K8', 'MAP2K6']",0.8787788445662238,0,0,5
298,Endometrial cancer WP4155,0.6803227759851165,0.8605794790005317,0.3314848219773822,"['BAX', 'CTNNA3']",0.8930532910532053,0,0,2
299,EGF/EGFR signaling pathway WP437,0.6831074812271727,0.8783823558267763,0.33475420842284975,"['GJA1', 'PLSCR1', 'RPS6KA5', 'LIMK2', 'STAT3', 'NCK2', 'IQGAP1']",0.8930532910532053,0,0,7
300,Intraflagellar transport proteins binding to dynein WP4532,0.6857373484872826,0.887855579868709,0.3349529274396652,['DYNLT3'],0.8930532910532053,0,0,1
301,Physiological and pathological hypertrophy of the heart WP1528,0.6857373484872826,0.887855579868709,0.3349529274396652,['STAT3'],0.8930532910532053,0,0,1
302,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6953370181963886,0.8351393188854489,0.3034550810108874,"['PFN1', 'PFN2']",0.8988788433674575,0,0,2
303,Thermogenesis WP4321,0.6989720773065831,0.8347769877181642,0.298970773667358,"['ACSL1', 'MGLL', 'CREB5']",0.8988788433674575,0,0,3
304,Aryl Hydrocarbon Receptor Pathway WP2873,0.7064499233644478,0.8355000643583472,0.29033874481819355,['BAX'],0.8988788433674575,0,0,1
305,EPO Receptor Signaling WP581,0.7064499233644478,0.8355000643583472,0.29033874481819355,['STAT3'],0.8988788433674575,0,0,1
306,GABA receptor Signaling WP4159,0.7064499233644478,0.8355000643583472,0.29033874481819355,['SLC6A1'],0.8988788433674575,0,0,1
307,Nanoparticle-mediated activation of receptor signaling WP2643,0.7064499233644478,0.8355000643583472,0.29033874481819355,['PXN'],0.8988788433674575,0,0,1
308,TLR4 Signaling and Tolerance WP3851,0.7064499233644478,0.8355000643583472,0.29033874481819355,['IKBKE'],0.8988788433674575,0,0,1
309,Leptin signaling pathway WP2034,0.7108480649079384,0.8185967878275571,0.27938427109087294,"['PTPN1', 'STAT3', 'BAX']",0.8988788433674575,0,0,3
310,Pancreatic adenocarcinoma pathway WP4263,0.7108480649079384,0.8185967878275571,0.27938427109087294,"['STAT3', 'BAX', 'E2F3']",0.8988788433674575,0,0,3
311,Retinoblastoma gene in cancer WP2446,0.7236160302676871,0.7884990253411306,0.2550749971934267,"['E2F3', 'SAP30']",0.9039498106244253,0,0,2
312,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7258001405626192,0.7889618283491369,0.25284695266080703,['BAX'],0.9039498106244253,0,0,1
313,Signal transduction through IL1R WP4496,0.7258001405626192,0.7889618283491369,0.25284695266080703,['MAP2K6'],0.9039498106244253,0,0,1
314,Type II interferon signaling (IFNG) WP619,0.7258001405626192,0.7889618283491369,0.25284695266080703,['OAS1'],0.9039498106244253,0,0,1
315,B Cell Receptor Signaling Pathway WP23,0.7263882406803417,0.8103209565764632,0.25903581905092604,"['BCL6', 'E2F3', 'PIK3AP1', 'MAP2K6']",0.9039498106244253,0,0,4
316,IL-3 signaling pathway WP286,0.7369060003359162,0.7670697012802276,0.23418249733055505,"['STAT3', 'CD69']",0.9112498456861453,0,0,2
317,Glycerophospholipid Biosynthetic Pathway WP2533,0.7438774250499145,0.7473223540251065,0.22111699751176647,['PGS1'],0.9112498456861453,0,0,1
318,Nephrotic syndrome WP4758,0.7438774250499145,0.7473223540251065,0.22111699751176647,['E2F3'],0.9112498456861453,0,0,1
319,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7438774250499145,0.7473223540251065,0.22111699751176647,['VMP1'],0.9112498456861453,0,0,1
320,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7438774250499145,0.7473223540251065,0.22111699751176647,['CREB5'],0.9112498456861453,0,0,1
321,Circadian rhythm related genes WP3594,0.7577678545062156,0.7870983566347804,0.21832392601047737,"['PER3', 'DBP', 'NR1D2', 'NR1D1', 'ARNTL']",0.9183226337649271,0,0,5
322,Amino Acid metabolism WP3925,0.7618559190722456,0.7275078722447144,0.19788055801607374,"['OAT', 'IDH1']",0.9183226337649271,0,0,2
323,Melanoma WP4685,0.7618559190722456,0.7275078722447144,0.19788055801607374,"['BAX', 'E2F3']",0.9183226337649271,0,0,2
324,MET in type 1 papillary renal cell carcinoma WP4205,0.7618559190722456,0.7275078722447144,0.19788055801607374,"['STAT3', 'JAK3']",0.9183226337649271,0,0,2
325,Osteoblast differentiation WP4787,0.7618559190722456,0.7275078722447144,0.19788055801607374,"['NOTCH1', 'RBPJ']",0.9183226337649271,0,0,2
326,Ebola Virus Pathway on Host WP4217,0.7637070882840975,0.7660435766162639,0.20650309900078165,"['BST2', 'IQGAP1', 'IKBKE', 'RHOB']",0.9183226337649271,0,0,4
327,Autophagy WP4923,0.7765419895692918,0.6759403980410545,0.17094841059406696,['ATG14'],0.928062377777934,0,0,1
328,Mitochondrial CIV Assembly WP4922,0.7765419895692918,0.6759403980410545,0.17094841059406696,['COX14'],0.928062377777934,0,0,1
329,Vitamin D-sensitive calcium signaling in depression WP4698,0.791280337129299,0.6451163715933956,0.15102365567939627,['CACNA1C'],0.9343683873830925,0,0,1
330,Pathways affected in adenoid cystic carcinoma WP3651,0.7954288928804647,0.6752297410192147,0.15454241148702674,"['NOTCH1', 'NFIB']",0.9343683873830925,0,0,2
331,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7954288928804647,0.6752297410192147,0.15454241148702674,"['NOTCH1', 'MGLL']",0.9343683873830925,0,0,2
332,Glycogen Synthesis and Degradation WP500,0.805048579675561,0.6169726952716202,0.1337921676252829,['PYGL'],0.9343683873830925,0,0,1
333,MAPK Cascade WP422,0.805048579675561,0.6169726952716202,0.1337921676252829,['MAP2K6'],0.9343683873830925,0,0,1
334,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.805048579675561,0.6169726952716202,0.1337921676252829,['STAT3'],0.9343683873830925,0,0,1
335,Neural Crest Cell Migration during Development WP4564,0.805048579675561,0.6169726952716202,0.1337921676252829,['STAT3'],0.9343683873830925,0,0,1
336,PDGFR-beta pathway WP3972,0.805048579675561,0.6169726952716202,0.1337921676252829,['STAT3'],0.9343683873830925,0,0,1
337,Target Of Rapamycin (TOR) Signaling WP1471,0.805048579675561,0.6169726952716202,0.1337921676252829,['PRR5'],0.9343683873830925,0,0,1
338,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8056543748354216,0.6594247246022031,0.14250197562852465,"['CYCS', 'BAX']",0.9343683873830925,0,0,2
339,Gastrin signaling pathway WP4659,0.810384858940071,0.6855015951790145,0.1441239750035908,"['PXN', 'STAT3', 'RHOB']",0.9370821967684597,0,0,3
340,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8179104405806009,0.5911743253099927,0.11882747843342145,['IGF1'],0.9402372220164094,0,0,1
341,G1 to S cell cycle control WP45,0.8179104405806009,0.5911743253099927,0.11882747843342145,['E2F3'],0.9402372220164094,0,0,1
342,Oxidative phosphorylation WP623,0.8247511181133607,0.6299220272904483,0.12136935301633547,"['ATP5MC3', 'ATP5MC1']",0.9453287669603432,0,0,2
343,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8299254661516134,0.5674398249452954,0.10578178151179585,['CYCS'],0.9484862470304153,0,0,1
344,Pathways Regulating Hippo Signaling WP4540,0.8336536709906841,0.6161327231121282,0.11209747816422215,"['CDH12', 'CDH18']",0.9499774390358958,0,0,2
345,CAMKK2  Pathway WP4874,0.8411492985302061,0.5455310553778825,0.09436929502237665,['CHRM3'],0.9502320605874376,0,0,1
346,Neural Crest Cell Migration in Cancer WP4565,0.8411492985302061,0.5455310553778825,0.09436929502237665,['STAT3'],0.9502320605874376,0,0,1
347,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8411492985302061,0.5455310553778825,0.09436929502237665,['STAT3'],0.9502320605874376,0,0,1
348,Focal Adhesion WP306,0.8580042926031054,0.6502607726973517,0.0995849510488268,"['PXN', 'SPP1', 'IGF1', 'DOCK1']",0.9647993025097361,0,0,4
349,Copper homeostasis WP3286,0.8614279486694072,0.506408252578931,0.07553781032564044,['STEAP3'],0.9647993025097361,0,0,1
350,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8614279486694072,0.506408252578931,0.07553781032564044,['BAX'],0.9647993025097361,0,0,1
351,Genotoxicity pathway WP4286,0.8705767476342362,0.48887044442767674,0.06775713006462725,['CEBPD'],0.965958829688897,0,0,1
352,Interleukin-11 Signaling Pathway WP2332,0.8705767476342362,0.48887044442767674,0.06775713006462725,['STAT3'],0.965958829688897,0,0,1
353,PDGF Pathway WP2526,0.8705767476342362,0.48887044442767674,0.06775713006462725,['STAT3'],0.965958829688897,0,0,1
354,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8723199635455856,0.555297557619539,0.07585308646663952,"['HMGCS1', 'SCD']",0.965958829688897,0,0,2
355,IL-6 signaling pathway WP364,0.8791227475415042,0.4725018234865062,0.06087276265029975,['STAT3'],0.9660287028001123,0,0,1
356,Cell cycle WP179,0.8853320268780848,0.53417742469381,0.06505882147521269,"['E2F3', 'YWHAG']",0.9660287028001123,0,0,2
357,Energy Metabolism WP1541,0.8871055844357914,0.4571892426060563,0.05476727923227353,['PPARD'],0.9660287028001123,0,0,1
358,IL-5 signaling pathway WP127,0.8871055844357914,0.4571892426060563,0.05476727923227353,['STAT3'],0.9660287028001123,0,0,1
359,Metapathway biotransformation Phase I and II WP702,0.8871055844357914,0.4571892426060563,0.05476727923227353,['SULT4A1'],0.9660287028001123,0,0,1
360,Regulation of Microtubule Cytoskeleton WP2038,0.8945622936643897,0.44283369803063455,0.04934085730991911,['STAT3'],0.9660287028001123,0,0,1
361,Splicing factor NOVA regulated synaptic proteins WP4148,0.8945622936643897,0.44283369803063455,0.04934085730991911,['EPB41L3'],0.9660287028001123,0,0,1
362,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8945622936643897,0.44283369803063455,0.04934085730991911,['CACNA1C'],0.9660287028001123,0,0,1
363,Wnt Signaling Pathway WP363,0.8945622936643897,0.44283369803063455,0.04934085730991911,['GJA1'],0.9660287028001123,0,0,1
364,T-cell receptor (TCR) signaling pathway WP69,0.8971081142061177,0.5145933014354067,0.05587397231619869,"['CD83', 'MAP3K8']",0.9661164306835113,0,0,2
365,RANKL/RANK signaling pathway WP2018,0.9015274799057651,0.42934818645978384,0.04450827429231862,['MAP2K6'],0.9682158140357806,0,0,1
366,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9080334764677404,0.4166559402754537,0.04019647880841777,['NOTCH1'],0.9725385868179077,0,0,1
367,Modulators of TCR signaling and T cell activation WP5072,0.9141104941370111,0.40468896530165677,0.0363426166527213,['MAP3K8'],0.9737263959285554,0,0,1
368,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9141104941370111,0.40468896530165677,0.0363426166527213,['TLR2'],0.9737263959285554,0,0,1
369,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9197867600738168,0.39338682227084854,0.03289241693731354,['MAP3K8'],0.9769511899872494,0,0,1
370,DNA damage response (only ATM dependent) WP710,0.9260207214055303,0.46354616048317515,0.03562754010755008,"['BCL6', 'BAX']",0.9769511899872494,0,0,2
371,DNA IR-damage and cellular response via ATR WP4016,0.9300407994039372,0.37256708510883335,0.02702110721253104,['BCL6'],0.9769511899872494,0,0,1
372,Nonalcoholic fatty liver disease WP4396,0.9315039520354997,0.542527956624873,0.038494987771405004,"['VMP1', 'XBP1', 'CYCS', 'BAX']",0.9769511899872494,0,0,4
373,Fragile X Syndrome  WP4549,0.9320911863653859,0.5042386185243328,0.035460394095223134,"['GRIP1', 'DUSP3', 'SLC6A1']",0.9769511899872494,0,0,3
374,Integrated breast cancer pathway WP1984,0.9320911863653859,0.5042386185243328,0.035460394095223134,"['BAX', 'SMAD6', 'BACH1']",0.9769511899872494,0,0,3
375,IL-1 signaling pathway WP195,0.9430216008832326,0.3451459678710573,0.020248364432915774,['MAP2K6'],0.9847505803805486,0,0,1
376,Kit receptor signaling pathway WP304,0.9503104128362323,0.3289908910488016,0.016767546293961273,['STAT3'],0.9847505803805486,0,0,1
377,Male infertility WP4673,0.9535980277324833,0.3214640938929779,0.015273739857827446,['ARNTL'],0.9847505803805486,0,0,1
378,Wnt signaling pathway and pluripotency WP399,0.9535980277324833,0.3214640938929779,0.015273739857827446,['PPARD'],0.9847505803805486,0,0,1
379,Head and Neck Squamous Cell Carcinoma WP4674,0.9566685568566998,0.31427182105519086,0.013921702096355038,['NOTCH1'],0.9847505803805486,0,0,1
380,Proteasome Degradation WP183,0.9566685568566998,0.31427182105519086,0.013921702096355038,['PSMD5'],0.9847505803805486,0,0,1
381,VEGFA-VEGFR2 Signaling Pathway WP3888,0.9571172732780332,0.6363636363636364,0.02789140608968006,"['PTPN1', 'GJA1', 'RPS6KA5', 'STAT3', 'PXN', 'CYCS', 'IQGAP1', 'ELOC', 'PFN1', 'PTPN14', 'HSPA1A', 'MAP2K6']",0.9847505803805486,0,0,12
382,Ras signaling WP4223,0.9608861332987029,0.44508964719491034,0.017758794181900538,"['GNG10', 'GNG3', 'KSR2']",0.9860402205578311,0,0,3
383,Corticotropin-releasing hormone signaling pathway WP2355,0.9670521737269228,0.28843835127048634,0.00966350126969294,['GJA1'],0.9871990940129003,0,0,1
384,Glioblastoma signaling pathways WP2261,0.9670521737269228,0.28843835127048634,0.00966350126969294,['MAP2K6'],0.9871990940129003,0,0,1
385,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.970187934729077,0.36631351105035315,0.011086653915630093,"['ATP5MC3', 'ATP5MC1']",0.9878277153605147,0,0,2
386,TGF-beta Signaling Pathway WP366,0.9777182001135074,0.34370988446726575,0.007745086154914945,"['LIMK2', 'MAP2K6']",0.9896796505519208,0,0,2
387,ErbB signaling pathway WP673,0.9822221256716933,0.24334113031011848,0.004365004280217933,['NCK2'],0.9896796505519208,0,0,1
388,Ciliary landscape WP4352,0.9834030821939579,0.4190939575251496,0.007014036011795347,"['CTSA', 'DOCK5', 'DYNLT3', 'IQGAP1']",0.9896796505519208,0,0,4
389,Mesodermal commitment pathway WP2857,0.9845014935015832,0.23515681983953318,0.003673117518413466,['SMAD6'],0.9896796505519208,0,0,1
390,Ciliopathies WP4803,0.986489126993976,0.22750052939930826,0.0030946841004776938,['CCDC65'],0.9896796505519208,0,0,1
391,Endoderm differentiation WP2853,0.9882222934749365,0.22032275711159738,0.0026102987934748484,['NOTCH1'],0.9896796505519208,0,0,1
392,mRNA Processing WP411,0.9896796505519208,0.2960757156048015,0.0030714816334843254,"['SNRPG', 'YBX1']",0.9896796505519208,0,0,2
